We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Human Peptide Database Project Will Facilitate Proteome Research

By LabMedica International staff writers
Posted on 08 Jun 2010
Print article
A major project is underway to amass a database that will allow researchers with access to a mass spectrometer to analyze almost any of the estimated 25,000 proteins encoded by the human genome.

The project, known as the Human Proteome MRMAtlas is being conducted by the nonprofit Institute for Systems Biology (Seattle, WA, USA) in collaboration with the major manufacturer of laboratory equipment Thermo Fisher Scientific Inc. (Milford, MA, USA).

During the two years that the project will be running, Thermo Fisher will provide researchers at the Institute for Systems Biology with up to 100,000 synthetic peptides. The investigators will use the synthetic peptides and mass spectrometry to identify and document at least four proteotypic, or unique, peptides for each human protein. In addition, the investigators will use thousands of custom Thermo Scientific HeavyPeptide AQUA standards to measure the abundance of the natural peptides and develop precise quantitative MRM/SRM assays.

The accumulated data will be published as a database available to researchers around the world.

"The time is right to create the complete human proteome MRMAtlas,” said Dr. Robert Moritz, associate professor and proteomics director at the Institute for Systems Biology. "This will undoubtedly accelerate efforts to develop sensitive and reliable assays for early detection, therapy assessment, and prognosis evaluation for cancer as well as other human diseases. It will pave a path to personalized medicine by improving the development of individually tailored therapies.”

"By reducing the time, effort, and cost to perform these assays, the database will dramatically increase the research output in biomarker discovery, confirmation, and validation,” said Joel Louette, commercial director for at Thermo Fisher. "We are proud to play a role in this project, which will speed up and decrease costs associated with drug development, boost personalized medicine, and support human health monitoring.”

Related Links:
Institute for Systems Biology
Thermo Fisher Scientific Inc.


Gold Member
Troponin T QC
Troponin T Quality Control
Automated Blood Typing System
IH-500 NEXT
New
Human Immunodeficiency Virus Assay
RealLine HIV Quantitative Kit
New
LH ELISA
Luteinizing Hormone ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.